| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 4e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |